This Is MS | Unbiased Multiple Sclerosis Research, News, and Community

Modules

· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

Google

These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

Languages

Select Interface Language:

Who's Online

There are currently, 222 guest(s) and 10 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.

Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!

This Is MS: Mobility

[ Go to Home | Select a New Topic ]

Clinical Trials: A New Drug for Spasticity in Multiple Sclerosis

A new study shows that the popular anti-epileptic drug levetiracetam reduced phasic spasticity, which is marked by spasms and painful muscle cramps, in 100 percent of patients with Multiple Sclerosis in a small clinical study. Spasticity is a key factor in many MS patients' loss of the ability to walk.

"It's amazing how many MS patients can't walk, can't move, and you treat their spasticity and they're fine," said Dr. Kathleen Hawker, assistant professor of neurology at UT Southwestern and lead author of the study. "What's nice about these drugs is that they also work for nerve pain, which in turn improves the patient's mood, so we can use one drug for three things instead of prescribing pain killers and antidepressants in addition to the spasticity therapies."

Read the full article by clicking "Read More" below.

Note: Besides the outstanding efficacy, also interesting is the very low side effect profile versus current treatments.

Posted by Administrator on Monday, December 15 @ 19:49:18 EST (2453 reads)
(Read More... | 4147 bytes more | Clinical Trials | Score: 4.63)

Login

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Survey

Big Story of Today

There isn't a Biggest Story for Today, yet.

Old Articles

There isn't content right now for this block.

Latest Forum Posts

Last 10 Forum Messages

diet for SPMS?

Can I get your opinions please?

PPMS - does it always mean the patient will end up bedbound?

Even Canadians love Texas

Gibbledygook's anti-viral log

Questions and responses to the 100 plus days club members

To Copaxone or not to Copaxone

Constipation as a Symptom of Multiple Sclerosis

Molecule has potential to regulate immune response <:3

Non-stop Eyelid-twitchings - My personal comments

[ This Is MS ]

Information

This site is privately funded by individuals interested in fighting multiple sclerosis.
There are no corporate grants, medical center affiliations, or overbearing advertisements, providing a truly independent online community for MS.

Note that all medical decisions should be made with the consent of your doctor.

Personal Stories about millions of life experience--including multiple sclerosis support, lupus support, depression support . Built by the This is MS team.

Anonymous Confessions | Dream Dictionary
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.

Visit our sister site dedicated to Inflammatory Bowel Disease: This is IBD

All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.12 Seconds